Positive Phase III results with Avastin in breast cancer patients

被引：0
|
作者：
不详
机构：
来源：
IMMUNOTHERAPY | 2009年 / 1卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Renal safety of ibandronate in patients with bone metastases from breast cancer:: phase III trial results
    Bell, R.
    Diel, I. J.
    Body, J.
    Bergstroem, B.
    EJC SUPPLEMENTS, 2004, 2 (03): : 132 - 132
  • [2] Lymph node ratio is an independent risk classifier in node positive breast cancer patients: results of the phase III BIG 02-98 trial
    Metzger, O.
    de Azambuja, E.
    Quinaux, E.
    Francis, P.
    Buyse, M.
    Crown, J.
    Andersson, M.
    Di Leo, A.
    Piccart-Gebhart, M.
    EJC SUPPLEMENTS, 2010, 8 (03): : 61 - 61
  • [3] Avastin loses breast cancer indication
    Karen Carey
    Nature Biotechnology, 2012, 30 (1) : 6 - 6
  • [4] Bevacizumab (Avastin) for metastatic breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1287): : 42 - 43
  • [5] Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer
    Coombes, R. C.
    Kilburn, L. S.
    Tubiana-Mathieu, N.
    Olmos, T.
    Van Bochove, A.
    Perez-Lopez, F. R.
    Palmieri, C.
    Stebbing, J.
    Bliss, J. M.
    EUROPEAN JOURNAL OF CANCER, 2016, 60 : 146 - 153
  • [6] PAIN IN PATIENTS WITH METASTATIC BREAST CANCER: RESULTS FROM A PHASE III TRIAL OF DENOSUMAB VERSUS ZOLEDRONIC ACID
    de Boer, R. H.
    Stopeck, A.
    Fallowfield, L.
    Patrick, D.
    Cleeland, C. S.
    Steger, G. G.
    Qian, Y.
    Dansey, R. D.
    Braun, A. H.
    Chung, K.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 40 - 40
  • [7] Zometa® is equally effective as pamidronate:: results of a phase III trial in breast cancer patients receiving chemotherapy.
    Rosen, L
    Gordon, D
    Kalman, LA
    Kaminski, M
    Munoz, M
    Ballester, O
    Pawl, LE
    Yunus, F
    Chen, B
    Seaman, J
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 305 - 305
  • [8] Phase III randomized trials of docetaxel in patients with metastatic breast cancer
    Crown, J
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 33 - 38
  • [9] Positive Phase III Results in ANCHOR Studies in CRSwNP
    Hofmann-Assmus, Marion
    ALLERGO JOURNAL, 2025, 34 (01) : 49 - 49
  • [10] Nilotinib approved thanks to positive Phase III results
    不详
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (04) : 377 - 377
12345